David C. Harmon
Harvard University · 145 works · 9,464 citations · h-index 58
Top works
- Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002
- Treatment of the patient with stage M0 soft tissue sarcoma.
- Preliminary results of a randomized trial of adjuvant doxorubicin for sarcomas: lack of apparent difference between treatment groups.
- Radiation therapy of retroperitoneal soft tissue sarcomas
- Acute thrombocytopenic purpura in relation to the use of drugs
- Multicenter Phase II Trial of Sunitinib in the Treatment of Nongastrointestinal Stromal Tumor Sarcomas
- Phase II and Pharmacokinetic Study of Ecteinascidin 743 in Patients With Progressive Sarcomas of Soft Tissues Refractory to Chemotherapy
- Ewing's sarcoma: surgical resection as a prognostic factor
- Treatment and Outcome of 82 Patients with Angiosarcoma
- Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas
- A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases
- Phase II Study of Neoadjuvant Chemotherapy and Radiation Therapy in the Management of High-Risk, High-Grade, Soft Tissue Sarcomas of the Extremities and Body Wall: Radiation Therapy Oncology Group Trial 9514
- Cardiac Angiosarcoma Management and Outcomes: 20-Year Single-institution Experience
- CD20-Directed Serotherapy in Patients With Multiple Myeloma: Biologic Considerations and Therapeutic Applications
- Phase II Study of High-Dose Photon/Proton Radiotherapy in the Management of Spine Sarcomas
- Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study
- Survival Data for 648 Patients with Osteosarcoma Treated at One Institution
- Primary Lymphoma of Bone
- Evaluation of Case Reports of Aplastic Anemia Among Patients Treated with Felbamate
- Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas